-
UMB Dataset
Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling
- Authors
- Peter DoshiBansri DesaiKyungwan HongJohn H. Powers, III
- Description
Clinicians prescribing therapeutic agents newly approved by the FDA must rely on the information reported through drug labels (also known as “package inserts”). Ideally, labels should incorporate details regarding key efficacy information, including the magnitude of treatment benefit, and measures of precision and random error (confidence intervals and p values). This study assessed the degree to which...
- Subject
-
Drug Labeling/standards
- Access Rights
- Unrestricted access